| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3898758 | Urology | 2015 | 7 Pages |
Abstract
Combined treatment with Akt1 inhibitor and sunitinib could be a promising therapeutic approach for men with castration-resistant prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Masatomo Nishikawa, Hideaki Miyake, Masato Fujisawa,